Erasers of histone acetylation: the histone deacetylase enzymes

E Seto, M Yoshida - Cold Spring Harbor perspectives in …, 2014 - cshperspectives.cshlp.org
Histone deacetylases (HDACs) are enzymes that catalyze the removal of acetyl functional
groups from the lysine residues of both histone and nonhistone proteins. In humans, there …

Histone deacetylases (HDACs): characterization of the classical HDAC family

AJM Ruijter, AH GENNIP, HN Caron, S Kemp… - Biochemical …, 2003 - portlandpress.com
Transcriptional regulation in eukaryotes occurs within a chromatin setting, and is strongly
influenced by the post-translational modification of histones, the building blocks of …

[PDF][PDF] Results from a pivotal, open-label, phase II study of romidepsin in relapsed or refractory peripheral T-cell lymphoma after prior systemic therapy

B Coiffier, B Pro, HM Prince, F Foss, L Sokol… - J Clin Oncol, 2012 - academia.edu
Results From a Pivotal, Open-Label, Phase II Study of Romidepsin in Relapsed or Refractory
Peripheral T-Cell Lymphoma After Prio Page 1 Results From a Pivotal, Open-Label, Phase II …

[HTML][HTML] Understanding the role of histone deacetylase and their inhibitors in neurodegenerative disorders: Current targets and future perspective

V Kumar, S Kundu, A Singh, S Singh - Current …, 2022 - ncbi.nlm.nih.gov
Neurodegenerative diseases are a group of pathological conditions that cause motor inc-
ordination (jerking movements), cognitive and memory impairments result from …

[PDF][PDF] Final results from a multicenter, international, pivotal study of romidepsin in refractory cutaneous T-cell lymphoma

SJ Whittaker, MF Demierre, EJ Kim, AH Rook… - J Clin …, 2010 - researchtopractice.com
Final Results from a Multicenter, International, Pivotal Study of Romidepsin in Refractory
Cutaneous T-Cell Lymphoma Page 1 Final Results from a Multicenter, International, Pivotal …

FIH-1: a novel protein that interacts with HIF-1α and VHL to mediate repression of HIF-1 transcriptional activity

PC Mahon, K Hirota, GL Semenza - Genes & development, 2001 - genesdev.cshlp.org
Hypoxia-inducible factor 1 (HIF-1) is a master regulator of oxygen homeostasis that controls
angiogenesis, erythropoiesis, and glycolysis via transcriptional activation of target genes …

Histone deacetylases and cancer: causes and therapies

PA Marks, RA Rifkind, VM Richon, R Breslow… - Nature Reviews …, 2001 - nature.com
Together, histone acetyltransferases and histone deacetylases (HDACs) determine the
acetylation status of histones. This acetylation affects the regulation of gene expression, and …

Histone-deacetylase inhibitors: novel drugs for the treatment of cancer

RW Johnstone - Nature reviews Drug discovery, 2002 - nature.com
The opposing actions of histone acetyltransferases (HATs) and histone deacetylases
(HDACs) allow gene expression to be exquisitely regulated through chromatin remodelling …

Environmental chemical exposures and human epigenetics

L Hou, X Zhang, D Wang… - International journal of …, 2012 - academic.oup.com
Every year more than 13 million deaths worldwide are due to environmental pollutants, and
approximately 24% of diseases are caused by environmental exposures that might be …

Histone deacetylase inhibitors: overview and perspectives

M Dokmanovic, C Clarke, PA Marks - Molecular cancer research, 2007 - AACR
Histone deacetylase inhibitors (HDACi) comprise structurally diverse compounds that are a
group of targeted anticancer agents. The first of these new HDACi, vorinostat …